Key facts
- This page summarizes Ian G. H. Ashken's Form 4 filing for APi Group Corp (APG).
- 3 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 05 Aug 2026, 16:47.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Sale
Sale
Sale
No transaction description listed
No transaction description listed
No transaction description listed
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
No transaction description listed
No transaction description listed
Additional SEC filing notes
Rule 10b5-1 trading plan
These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.
Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).
Footnote F1
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Nancy and Ian Ashken Investment Trust LLLP (the "Ashken Investment Trust") on March 18, 2026.
Footnote F2
Represents the weighted average price of the shares sold on August 3, 2026. The prices of the shares sold pursuant to the transactions ranged from $39.75 to $40.13 per share. The Ashken Investment Trust, upon request, will provide the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares sold at each separate price.
Footnote F3
The shares of Common Stock reported herein are held directly by the Ashken Investment Trust, the general partner of which is wholly-owned by The Ian G.H. Ashken Living Trust (the "Ashken Trust"), of which Mr. Ashken is the trustee and beneficiary. Mr. Ashken disclaims beneficial ownership of any shares except to the extent of his pecuniary interest therein.
Footnote F4
Represents the weighted average price of the shares sold on August 4, 2026. The prices of the shares sold pursuant to the transactions ranged from $39.75 to $40.745 per share. The Ashken Investment Trust, upon request, will provide the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares sold at each separate price.
Footnote F5
Represents the weighted average price of the shares sold on August 4, 2026. The prices of the shares sold pursuant to the transactions ranged from $40.75 to $40.765 per share. The Ashken Investment Trust, upon request, will provide the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares sold at each separate price.
Footnote F6
Held jointly in an account by the Ashken Trust and the Nancy K. Ashken Living Trust.
Footnote F7
The shares of Common Stock reported herein are held directly by the Ashken Trust, of which Mr. Ashken is the trustee and beneficiary. Mr. Ashken disclaims beneficial ownership of any shares except to the extent of his pecuniary interest therein.
Footnote F8
The shares of Common Stock and Series A Preferred Stock are held directly by Mariposa Acquisition IV, LLC. The Ashken Investment Trust, the general partner of which is wholly-owned by the Ashken Trust, of which Mr. Ashken is the trustee and beneficiary, holds a limited liability company interest in Mariposa Acquisition IV, LLC and, as a result, may be deemed to have a pecuniary interest in 15,552 shares of Common Stock and 1,152,000 shares of Series A Preferred Stock held by Mariposa Acquisition IV, LLC. Mr. Ashken disclaims beneficial ownership of any shares except to the extent of his pecuniary interest therein.
Footnote F9
The Series A Preferred Stock will convert into Common Stock at the option of the holder or automatically as of December 31, 2026.
Footnote F10
Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock.
Footnote F11
These restricted stock units vest on May 15, 2027, which is the one-year anniversary of the grant date, subject to the Reporting Person's continuous service with the Issuer as of the vesting date.